List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #55,021 to #55,070.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. U.parvum → Ureaplasma urealyticum
  2. U.urealyticum → Ureaplasma urealyticum
  3. U.urealyticum biovar 1 → Ureaplasma urealyticum
  4. U4EA → 4-Methyl-aminorex
  5. UA → Unstable angina / non ST elevation myocardial infarction
  6. UA/NSTEMI ACC/AHA guidelines for immediate management → Unstable angina / non ST elevation myocardial infarction ACC/AHA guidelines for immediate management
  7. UA/NSTEMI inhibitors of RAS → Unstable angina / non ST elevation myocardial infarction inhibitors of RAS
  8. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines Nonsteroidal Anti-Inflammatory Drugs → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines nonsteroidal anti-inflammatory drugs
  9. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines antioxidant vitamins and folic acid → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines antioxidant vitamins and folic acid
  10. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines depression → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines depression
  11. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for CCB → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for calcium channel blockers
  12. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for Physical Activity → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for physical activity
  13. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for antiplatelet therapy → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for antiplatelet therapy
  14. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for beta blockers → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for beta blockers
  15. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for blood pressure control → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for blood pressure control
  16. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for diabetes mellitus → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for diabetes mellitus
  17. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for inhibitors of the RAS → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for inhibitors of the RAS
  18. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for lipid management → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for lipid management
  19. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for nitroglycerin → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for nitroglycerin
  20. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for smoking cessation → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for smoking cessation
  21. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for warfarin therapy → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for warfarin therapy
  22. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for weight management → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for weight management
  23. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines hormone therapy → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines hormone therapy
  24. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines influenza vaccination → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines influenza vaccination
  25. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines patient education → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines patient education
  26. UAD Caine → Lidocaine
  27. UAP → Unstable angina / non ST elevation myocardial infarction
  28. UA / NSTEMI prehospital care → Unstable angina / non ST elevation myocardial infarction prehospital care after onset
  29. UA / NSTEMI prehospital care after onset → Unstable angina / non ST elevation myocardial infarction prehospital care after onset
  30. UA / NSTEMI prehospital care before onset → Unstable angina / non ST elevation myocardial infarction prehospital care before onset
  31. UBC → Unicameral bone cyst
  32. UBC (gene) → Ubiquitin C
  33. UC → Ulcerative colitis
  34. UCC → Transitional cell carcinoma
  35. UCP1 → Thermogenin
  36. UCSF-SCOR → UCSF-SCOR trial
  37. UDP-N-acetylmuramoylalanine-D-glutamate ligase → UDP-N-acetylmuramoyl-L-alanine-D-glutamate ligase
  38. UDP-N-acetylmuramoylalanyl-tripeptide-D-alanyl-D-alanine ligase → UDP-N-acetylmuramoyl-tripeptide-D-alanyl-D-alanine ligase
  39. UDP-galactose → Uridine diphosphate galactose
  40. UDP-galactose-4-epimerase deficiency → Galactose epimerase deficiency
  41. UDP-glucose → Uridine diphosphate glucose
  42. UDP-glucuronic acid → Uridine diphosphate glucuronic acid
  43. UDP-glucuronosyl transferase-2B7 → UGT2B7
  44. UDP-glucuronosyltransferase → Glucuronosyltransferase
  45. UDP-glucuronyltransferase → Glucuronosyltransferase
  46. UDPgalactose-4-epimerase → UDP galactose epimerase
  47. UFH → Heparin
  48. UH → Heparin
  49. UICC → International Union Against Cancer
  50. UK-TIA → The United Kingdom Transient Ischemic Attack Aspirin Trial: Final Results

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"